Highlights and Quick Summary
- Total non-current assets for the quarter ending September 30, 2022 was $49.6 Million (a 216.18% increase compared to previous quarter)
- Year-over-year quarterly Total non-current assets increased by 125.27%
- Annual Total non-current assets for 2021 was $22 Million (a 101.69% increase from previous year)
- Annual Total non-current assets for 2020 was $10.9 Million (a -0.2% decrease from previous year)
- Annual Total non-current assets for 2019 was $10.9 Million (a -66.34% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current assets of BioCryst Pharmaceuticals, Inc.
Most recent Total non-current assetsof BCRX including historical data for past 10 years.Interactive Chart of Total non-current assets of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Total non-current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $49.59 | $15.69 | $16.01 | – |
| 2021 | $22.02 | $13.02 | $11.48 | $10.66 | $22.02 |
| 2020 | $10.92 | $13.79 | $10.87 | $11.08 | $10.92 |
| 2019 | $10.94 | $11.7 | $12.63 | $24.69 | $10.94 |
| 2018 | $32.49 | $39.81 | $43.98 | $51.22 | $32.49 |
| 2017 | $52.87 | $16.12 | $21.25 | $16.01 | $52.87 |
| 2016 | $22.86 | $26.87 | $36.11 | $52.46 | $22.86 |
| 2015 | $58.57 | $54.45 | $43.09 | $48.5 | $58.57 |
| 2014 | $47.53 | $1.98 | $3.73 | $7.66 | $47.53 |
| 2013 | $6.75 | $6.37 | $6.39 | $11.49 | $6.75 |
| 2012 | $15.46 | $17.51 | $31.17 | $27.14 | $15.46 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology